4-Methyl-5-phenyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I
Authors:
- 1 June 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (11) , 3405-3411
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Attenuating pregnane X receptor (PXR) activation: A molecular modelling approachXenobiotica, 2007
- Local Amplification of Glucocorticoids by 11β‐Hydroxysteroid Dehydrogenase Type 1 and Its Role in the Inflammatory ResponseAnnals of the New York Academy of Sciences, 2006
- 11β‐Hydroxysteroid dehydrogenase type 1‐driven cortisone reactivation regulates plasminogen activator inhibitor type 1 in adipose tissue of obese womenJournal of Thrombosis and Haemostasis, 2006
- Adamantyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1Bioorganic & Medicinal Chemistry Letters, 2005
- 11β-Hydroxysteroid dehydrogenase-1 as a therapeutic target for metabolic diseasesExpert Opinion on Therapeutic Patents, 2005
- A rapid screening assay for inhibitors of 11β-hydroxysteroid dehydrogenases (11β-HSD): flavanone selectively inhibits 11β-HSD1 reductase activityMolecular and Cellular Endocrinology, 2003
- Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2Journal of Clinical Investigation, 1999
- Inhibition of Stromelysin-1 (MMP-3) by P1‘-Biphenylylethyl Carboxyalkyl DipeptidesJournal of Medicinal Chemistry, 1997
- Hypercortisolism and ObesityAnnals of the New York Academy of Sciences, 1995
- Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzymeMolecular and Cellular Endocrinology, 1994